ADC Technologies & Analytical Services & Worldwide Leading PEG Supplier
Facebook Twitter YouTube linkedin
1-858-677-9432
sales@axispharm.com
Hello, Sign in
Tracking & Orders
1-858-677-9432
sales@axispharm.com
AxisPharm AxisPharm
  • Home
  • Services
    • Service Area
      • Proteomics Services
        • DIA Proteomics Services
        • Intact Protein Analysis
        • Label Free Protein Quantification and Identification
        • Protein sequencing and quantification – TMT
        • Post Translational Modification Analysis
      • Metabolomics Services
        • Targeted Metabolomics Services
          • Amino Acid Panel
          • Bile Acid Panel
          • Carbohydrates Panel
          • Free Fatty Acid Panel
          • Lipids Panel
          • Steroid Hormones Panel
        • Untargeted Metabolomics Services
      • Lipidomics Services
      • Analytical Services
      • Bioconjugation Service
        • Formulation Services
        • Custom Synthesis Services
    • Service Area
      • Bioanalytical Services
        • Bioanalytical Method Development and Validation Services
        • Non-GLP and Discovery Bioanalysis Services
        • Bioanalytical Mass Spectrometry Services
        • In Vitro ADME Services
        • In Vivo DMPK Analysis Services
        • Ligand Binding Assay Bioanalysis Services
      • In Vitro Diagnostic (IVD) Research and Development
        • Chemiluminescence immunoassay (CLIA)
        • Enzyme-linked immunosorbent assay (ELISA)
        • Fluorescence immunoassay (FIA)
        • Latex-enhanced immunoturbidimetry (LETIA)
    • Test Type
      • HRMS and LC-HRMS Analysis Services
      • ICP-MS Analysis Services
      • Ion Chromatography – HPIC
      • LCMS Analysis
      • LCMSMS Analysis
      • GCMS Analysis
      • Maldi-TOF Analysis
      • Q-TOF-LC-MS and TQ-LC-MS analysis of Oligonucleotides
      • Titrations
    • Analyte Type
      • Chemical Testing
      • Small Molecule Analysis
      • Protein
      • Oligonucleotides
      • Polymers
      • Consumer Products Analysis
      • Environmental Analysis
      • Forensic
      • Pharmaceutical
  • Products
    • PEG Linkers
    • Lipids for Drug Delivery
    • Fluorescent Dye
    • Click Chemistry Reagents
    • Poly-PEG,Copolymer
    • Cleavable Linkers
    • Antibody-and-antibody-drug-conjugate-adc
    • ADC Payloads
    • Cell Biology Reagents
    • DNA
    • Modifier
    • Probes
    • Synthetic-peptides
    • Thiol reactive
    • Acid reactive
    • Amine reactive
    • Carbonyl reactive
    • Acid PEG
    • Aldehyde PEG
    • Alkyne PEG
    • Amino PEG
    • Aminooxy PEG
    • APN Linkers
    • Azide PEG
    • BCN-PEG
    • Benzyl-PEG
    • Biotin PEG
    • Bis-PEG-NHS
    • Bis-PEG-acid
    • Bis-Sulfone PEG
    • Boc-PEG
    • Branched PEG
    • Bromo PEG
    • Cleavable Linkers
    • DBCO PEG
    • DNP PEG
    • DOTA PEG
    • DSPE PEG
    • Diketone PEG
    • Fluorescent PEG
    • Fmoc PEG
    • Folate PEG
    • Homobifunctional PEG
    • HyNic PEG
    • Hydrazide PEG
    • Hydroxy PEG
    • Iodo PEG
    • Lipid PEG
    • M-PEG
    • Maleimide PEG
    • MeNH-PEG
    • NHS ester PEG
    • Non-PEG linker
    • PEG-X-PEG
    • PEG-t-butyl ester
    • PFP ester PEG
    • PROTAC PEG
    • Peptide Linkers
    • Phosphonate PEG
    • Polymer PEG
    • Propargyl PEG
    • SPDP PEG
    • Silane PEG
    • Sugar PEG
    • Sulfonic acid PEG
    • TCO PEG
    • Tetrazine PEG
    • Thiol PEG
    • Tosylate PEG
    • PEG Linkers By Modular Weight
    • Biotinyl Cap PE
    • Biotinyl PE
    • Caproylamine PE
    • Cationic Lipid
    • Cyanur PE
    • Dodecanyl PE
    • Glutaryl PE
    • Ionizable Lipid
    • MPB PE
    • PDP PE
    • PE MCC
    • Phosphatidylcholine
    • Phosphatidylethanolamine
    • Phosphoglycerol
    • Phosphoserine
    • Ptd Thioethanol
    • Succinyl PE
    • Lipid-PEG
    • APDye Fluors
      • APDye Fluor 350
      • APDye Fluor 405
      • APDye Fluor 430
      • APDye Fluor 488
      • APDye Fluor 532
      • APDye Fluor 546
      • APDye Fluor 555
      • APDye Fluor 568
      • APDye Fluor 594
      • APDye Fluor 633
      • APDye Fluor 647
      • APDye Fluor 660
      • APDye Fluor 680
      • APDye Fluor 800
    • Cyanine Dyes
      • Cyanine 3 Dye
      • Cyanine3.5 Dye
      • Cyanine5 Dye
      • Cyanine5.5 Dye
      • Cyanine7 Dye
      • Cyanine7.5
      • Sulfo Cyanine3 Dye
      • Sulfo Cyanine5 Dye
      • Sulfo-Cyanine3.5
      • sulfo-Cyanine5.5
      • sulfo-Cyanine7
      • sulfo-Cyanine7.5
    • MB Dyes
      • MB 488 Dye
      • MB 532 Dye
      • MB 543 Dye
      • MB 594 Dye
      • MB 633 Dye
      • MB 660R Dye
      • MB 680R Dye
      • MB 700R Dye
      • MB 800Z Dye
    • Others
      • AF Dyes
      • Bodipy Probes
      • Classic Fluorescent Dyes
      • Coumarin 343
      • DNP PEG
      • Fluorescein(FAM)
      • Haptens
      • IR Fluors
      • JOE
      • MB Dyes
      • Peptide Labeling Reagents
      • Pyrene Probes
      • Quenchers
      • R6G
      • Rhodamine Dye
      • Rox Dye
      • TAMRA Dye
    • Alkyne PEG
    • BCN-PEG
    • DBCO PEG
    • Methylcyclopropene-linkers
    • TCO-PEG
    • Tetrazine-PEG
    • PTDA Linkers
    • Azide PEG
    • Click Chemistry Auxiliary Reagents
    • Acrylate
    • Active ester
    • Aldehyde
    • Amine
    • Azide
    • Biotin
    • Boc
    • Carboxylic acid
    • Cholesterol
    • DBCO
    • Fmoc
    • Folate
    • Hydrazide
    • Hydroxyl
    • Lipoamide
    • Maleimide
    • Polysarcosine
    • Silane
    • Stearic acid
    • TCO
    • Thiol
    • -S-S- Cleavable
    • Cleavable Peptide
    • Dde Cleavable Linkers
    • Disulfide Biotin
    • PC Cleavable
    • Photocleavable Biotin
    • diazo biotin probes
    • β-Glucuronide Linkers
    • DTSSP crosslinker
    • Antibody
    • Antibody-drug-conjugates
    • Payloads and Linker modified Payloads
    • Cell Biology Reagents
    • CPG Solid Supports
    • Modified Triphosphates
    • PCR/qPCR stain
    • Phosphoramidite
    • Drug Formulation
    • Surface Modifier
    • Biotin PEG
    • Fluorescent Dye
    • Folate PEG
    • Image Probes
    • PROTAC PEG
    • Synthetic-peptides
    • Bromo PEG
    • Cleavable PEG
    • PEG Maleimide
    • PEG Tosylate
    • Amino PEG
    • Aminooxy PEG
    • MeNH-PEG
    • Bromo PEG
    • PEG Acid
    • PEG Aldehyde
    • PEG Maleimide
    • PEG NHS ester
    • PEG Tosylate
    • Aminooxy PEG
    • PEG hydrazide
    • Polyethylene Glycol PEG Linkers
    • Cleavable Linkers
    • Amine reactive Linkers
    • Acid reactive Linkers
    • Thiol reactive Linkers
    • Carbonyl reactive Linkers
    • Modifier
    • Probes
    • Other Linkers
  • Instrumentation
    • Agilent 1290 Infinity UPLC/ AB Sciex 5500 Qtrap Mass Spectrometer
    • Bruker timsTOF Pro 2
    • Bruker Autoflex Max MALDI-TOF MS
    • Orbitrap Fusion Lumos Tribrid Mass Spectrometer
    • Orbitrap Mass Spectrometer
    • GCMS
    • ICP-MS
    • Ion Chromatography – HPIC
    • LCMS
    • Maldi-TOF
    • Q-TOF-LC-MS and TQ-LC-MS
    • Titrations
    • TOF and QTOF Mass Spectrometer
  • Quick Links
    • Sample Preparation Guidelines
    • Online Sample Submission
    • Sample Submission Form (PDF)
    • GCMS GCFID Pricing
    • Analytical Pricing
    • PK Study Pricing
    • Proteomics Pricing
    • Metabolomics Services Pricing
    • Protocols
  • Blog
  • Contact Us
    • About Us
    • Product Support
    • Services and Products Cited
    • Videos
    • News
    • FAQ
    • Careers
0 items / $0.00
Menu
AxisPharm AxisPharm
0 items / $0.00

PEG & ADC

Home » Archive by Category "PEG & ADC"
18 Nov
PEG & ADC

How Linker Design Drives the Success of Antibody-Drug Conjugates (ADCs)

  • November 18, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
In the early stages of ADC development, researchers often overlooked linker design, thinking that adding...

Continue reading

24 Oct
PEG & ADC

Comparison of Label-Free Protein Quantification in Saliva: Fusion Lumos vs. TimsTOF Pro2

  • October 24, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Comparison of Label-Free Protein Quantification in Saliva: Fusion Lumos vs. TimsTOF Pro2 This comparison of Fusion Lumos a...

Continue reading

23 Oct
PEG & ADC

From Design to Degradation: The Essential Role of Linkers in PROTACs

  • October 23, 2024
  • By admin
Facebook Twitter Pinterest linkedin
PROTAC (Proteolysis Targeting Chimera) technology is revolutionizing drug development by targeting disease-causing proteins d...

Continue reading

17 Oct
PEG & ADC

What are Degrader Antibody Conjugates (DACs): How PROTACs are Transforming Targeted Therapy

  • October 17, 2024
  • By admin
Facebook Twitter Pinterest linkedin
What are Degrader Antibody Conjugates (DACs): How PROTAC PEGs are Transforming Targeted Therapy Degrader Antibody Conjugates (DACs) ar...

Continue reading

17 Oct
Protein Science, PEG & ADC

Targeting Cancer: Discover the Power of Folate Receptor Chimeras (FRTAC) for Selective Degradation

  • October 17, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Mechanism of Action Folate Receptor Chimeras (FRTACs) are designed to leverage the strong binding of folate receptors (FRs) to folate c...

Continue reading

08 Oct
PEG & ADC

How Bispecific Antibodies Like MCLA-158 are Changing Cancer Treatment with ADCs

  • October 8, 2024
  • By admin
Facebook Twitter Pinterest linkedin
A bispecific antibody (BsAb) is a type of engineered antibody that can bind two different antigens or epitopes simultaneously. With...

Continue reading

03 Oct
PEG & ADC

Comprehensive List of FDA-Approved Antibody-Drug Conjugates (ADCs) – Updated for 2024

  • October 3, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Comprehensive List of FDA-Approved Antibody-Drug Conjugates (ADCs) – Updated for 2024 Overview: Antibody-Drug Conjuga...

Continue reading

01 Oct
Lipids, PEG & ADC

PEG Lipids: Enhancing Drug Delivery and Therapeutic Efficacy

  • October 1, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
What Are PEG Lipids? PEG lipids, or PEGylated lipids, peg conjugated lipidsare polyethylene glycol (P...

Continue reading

25 Sep
PEG & ADC

Oxime and Hydrazone Reactions in Bioconjugation [with Top 10 most Asked Questions About Oxime and Hydrazone Reactions]

  • September 25, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Oxime and Hydrazone Reactions: Essential Tools in Bioconjugation Introduction Oxime and hydrazone reactions are widely used in biocon...

Continue reading

24 Sep
PEG & ADC

Mastering Maleimide Reactions in Bioconjugation: Your Ultimate Hands-On Guide

  • September 24, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Overview The maleimide reaction, particularly the thiol-maleimide reaction, is a cornerstone of bioconjugation, commonly used ...

Continue reading

24 Sep
PEG & ADC

PEG Linkers Explained: Types, Uses, and Why They Matter in Bioconjugation

  • September 24, 2024
  • By admin
Facebook Twitter Pinterest linkedin
PEG Linkers: Versatile Tools for Bioconjugation and Drug Delivery PEG (Polyethylene Glycol) linkers are essential components in the fi...

Continue reading

Comprehensive Statistical Analysis of Phosphoramidites: Market Trends, Applications, and Innovations
18 Sep
PEG & ADC

Comprehensive Statistical Analysis of Phosphoramidites: Market Trends, Applications, and Innovations

  • September 18, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Interactive Table of Contents

Continue reading

17 Sep
PEG & ADC

12 most commonly asked questions about phosphoramidites

  • September 17, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Commonly Asked Questions About Phosphoramidites 1. What are phosphoramidites used for? Phosphoramidites are the building blocks for...

Continue reading

10 Sep
PEG & ADC

Comprehensive Guide for Surface Modification Protocols with Chemical Linkers

  • September 10, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Comprehensive Surface Modification Protocols with Chemical Linkers Surface modification with chemical linkers i...

Continue reading

03 Sep
PEG & ADC

PDC: A Complement to ADC or a New Frontier?

  • September 3, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Exploring new types of drugs is a continuous endeavor in the pharmaceutical industry. After small molecules consi...

Continue reading

27 Aug
PEG & ADC

Ultimate Guide to Choosing the Right Biotin PEG Linker

  • September 26, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Introduction Biotin PEG linkers are essential tools in biochemical research and biotechnology for conjugating biotin to proteins, pe...

Continue reading

19 Aug
PEG & ADC

Ultimate Guide to Choosing the Right Cleavable Linker for ADCs

  • October 25, 2024
  • By admin
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADCs) are sophisticated therapeutic agents designed to target and kill cancer cells while minimizing damage t...

Continue reading

04 Aug
PEG & ADC

Understanding ADCs: An Introduction to Targets

  • August 4, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
ADC (Antibody-Drug Conjugates) are targeted drugs composed of antibodies, linkers, and cytotoxic drugs. They use ...

Continue reading

11 Jul
PEG & ADC

Unlocking the Power of AOCs: How Antibody-Oligonucleotide Conjugates Are Shaping the Future of Precision Medicine

  • October 5, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
The Rise of Antibody-Oligonucleotide Conjugates (AOCs) In the past decade, Antibody-Drug Conjugates (ADCs) have...

Continue reading

02 Jul
PEG & ADC

An Introduction to Linkers in Antibody-Drug Conjugates (ADCs)

  • September 30, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADCs) are “biological bullets” that combine cytotoxic drugs (payloads) with antibodies ...

Continue reading

27 Jun
PEG & ADC

ADC Drugs Already Marketed Globally: Compilation of Technical Reviews

  • June 27, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
ADC (Antibody Drug Conjugate) is a complex that connects cytotoxic drugs to monoclonal antibodies targeting tumor...

Continue reading

17 Jun
PEG & ADC

A Comprehensive Introduction to Bispecific ADCs

  • June 20, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADCs) consist of an antibody, a linker, and a cytotoxic payload. Compared to traditiona...

Continue reading

10 Jun
PEG & ADC

ADC Conjugation Technologies

  • June 10, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
This article introduces conjugation technologies based on carbonyl, amide, azido, and other amino acid funct...

Continue reading

06 Jun
PEG & ADC

Advances in ADC Linker Research

  • June 6, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Due to improvements in payloads, linkers, and conjugation methods, antibody-drug conjugates (ADCs) have seen sign...

Continue reading

29 May
PEG & ADC

Cleavable Linkers Play a Pivotal Role in the Success of Antibody-Drug Conjugates (ADCs)

  • August 18, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Cleavable linkers used in ADC development can release drugs under specific conditions, such as changes in pH, th...

Continue reading

22 May
PEG & ADC

Next-Generation of Novel Antibody-Drug Conjugates: Click Chemistry ADCs

  • May 22, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Currently, ADCs used in clinical settings mostly rely on effective internalization and transport to intracellular...

Continue reading

20 May
PEG & ADC

The High Hydrophilicity of ADC Linker Has Become the Main Trend in Modification

  • May 20, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Founded in 2018, ProfoundBio originated in Seattle, Washington, USA. The three core founders are Dr. Baiteng Zhao...

Continue reading

13 May
AxisPharm Services, PEG & ADC

Analysis of Multiple Factors Influencing ADC Pharmacokinetics

  • June 25, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADCs) are complex molecules wherein monoclonal antibodies are linked to cytotoxic drugs...

Continue reading

08 May
PEG & ADC

What is BCN:A Versatile Bioconjugation Tool

  • September 7, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
The BCN moiety is a strained cyclooctyne, which can react selectively with azide groups to form a stable triazole...

Continue reading

05 May
PEG & ADC

Challenges in Antibody-Drug Conjugate (ADC) Development

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
The next generation of ADCs employs enhanced strategies to achieve optimal stability and specificity, thereby imp...

Continue reading

27 Apr
PEG & ADC

ADC: All You Need to Know About Targeting, Termination, Optimization, and Phase II/III Clinical Trials

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
After decades of development, ADC drugs have entered a mature stage, with 15 ADCs approved globally and several A...

Continue reading

23 Apr
AxisPharm Services, PEG & ADC

XDC | Various New Drug Conjugates, In Addition to ADC, There Are More Choices.

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
With the continuous development of technology, the boundaries of drug conjugates are constantly expanding. Throug...

Continue reading

01 Apr
PEG & ADC

ADC to XDC, Five Major Elements of Antibody Conjugate Drugs, Exploring the Fundamental Source of Innovation

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
From ADC to XDC, the future trend of conjugated drugs will focus on new target antigens, payloads with new mechan...

Continue reading

17 Mar
PEG & ADC

Click Chemistry: The Go-To Toolkit for Fast and Efficient Reactions

  • September 25, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Click Chemistry: The Go-To Toolkit for Fast and Efficient Reactions What is Click Chemistry? Click chemistry is ...

Continue reading

25 Jan
PEG & ADC

What is BiotinylationProtein?

  • April 25, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Chemical Methods of Protein Biotinylation Protein biotinylation, a vita...

Continue reading

25 Sep
PEG & ADC

What are Ionizable Lipids?

  • October 8, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Ionizable Lipids Overview Ionizable lipids are lipid molecules that stay neutral at normal physiological pH but...

Continue reading

25 Sep
PEG & ADC

What are Cationic Lipids?

  • September 26, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
Cationic lipids belong to a group of lipid molecules characterized by a permanently positively charged head group...

Continue reading

28 Jun
PEG & ADC

Polyethylene Glycol Classification

  • October 21, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
The Ultimate Guide to Polyethylene Glycol (PEG): Classification, Properties, and Applications Polyethylene Glyc...

Continue reading

20 Jun
PEG & ADC

Solid Lipid Nanoparticles (SLNs)

  • June 20, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
Solid lipid nanoparticles (SLNs) have emerged as a promising drug delivery system due to their various advantage...

Continue reading

19 Jun
PEG & ADC

In Vitro vs In Vivo Studies of Polyethylene Glycol (PEG) Linkers

  • April 24, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Polyethylene glycol (PEG) molecules have been used extensively as linkers in drug development, mainly due to thei...

Continue reading

22 May
PEG & ADC

Why Human epidermal growth factor receptor 2 (HER2) is an attractive target for ADC

  • May 25, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that ...

Continue reading

10 Feb
PEG & ADC

What is the difference between ADC linker and PEG linker?

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Linkers are molecules used to connect two different molecules together to form a larger, more complex structure. They are used in many ...

Continue reading

09 Feb
PEG & ADC

Application of PEG Linker

  • July 21, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
A PEG (polyethylene glycol) linker is a chemical compound that is used to connect two or more molecules together. PEG is a water-solubl...

Continue reading

14 Nov
PEG & ADC

What is biotinylation?

  • October 15, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Biotinylation: Techniques and Applications Introduction Biotinylation is the process of attaching biotin to proteins, pep...

Continue reading

11 Nov
PEG & ADC

What are the ingredients of a COVID-19 vaccine?

  • November 11, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
What is an mRNA vaccine? Like other types of vaccines, mRNA vaccines work by activating our own immune response, so that our bodies pro...

Continue reading

10 Nov
PEG & ADC

The Importance of Polyethylene Glycol (PEG) to the Pharmaceutical Industry

  • December 13, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
Polyethylene glycol (PEG) is a safe, inactive, and nontoxic polymer that is commonly used for molecular modification. Therapeutic benef...

Continue reading

09 Nov
PEG & ADC

Technical characteristics of PROTAC technology in drug research and development

  • November 9, 2022
  • By 乐无琼
Facebook Twitter Pinterest linkedin
Most of the drugs currently in clinical use are based on small molecules and use an "occupancy-driven" mode of action to inhibit the fu...

Continue reading

08 Nov
PEG & ADC

What is SPDP Crosslinker?

  • November 8, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive grou...

Continue reading

05 Nov
PEG & ADC

Difference Between Polymer PEG (Polydisperse PEG) and Monodisperse PEG

  • July 21, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
The polymer PEG is a polyethylene glycol (PEG) polymer, a polyether compound derived from petroleum that has many applications ranging ...

Continue reading

04 Nov
PEG & ADC

What is polyethylene glycol (PEG) modification?

  • March 24, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Polyethylene glycol (PEG) modification is a polyethylene glycol with functional groups, which is mainly used for protein drug modificat...

Continue reading

28 Oct
PEG & ADC

What are ADC Linkers?

  • October 5, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADCs) are the most popular chemoimmunotherapy agents in recent years. ADCs can enhance the ability to target ...

Continue reading

18 Oct
PEG & ADC

The list of PEGylated drugs approved by FDA Up to 2024

  • March 28, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Polyethylene glycol (PEG) is a polymer material that is widely used for covalent modification of biopolymers such as proteins and pepti...

Continue reading

30 Sep
PEG & ADC

What is polyethylene?

  • October 25, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Overview Polyethylene (PE) is a versatile thermoplastic resin made by polymerizing ethylene, often with small amounts of alpha-olefi...

Continue reading

27 Sep
PEG & ADC

GLP-1 receptor agonist Drug list and mechanism of action

  • September 26, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs commonly used for the treatment of type 2 diabetes and, more rec...

Continue reading

28 Aug
PEG & ADC

Stem cells successfully repair refractory type 1 diabetes

  • August 28, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
With the improvement of people's living standard, the incidence of diabetes is increasing day by day. This poses ...

Continue reading

27 Aug
PEG & ADC

ADC drug for urothelial carcinoma( effective rate 81.6%)

  • October 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Urothelial carcinoma (UC) is a common type of bladder cancer, accounting for approximately 90% of all bladder can...

Continue reading

18 Aug
PEG & ADC

Can changing your diet help fight cancer?

  • August 18, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
An article published on «Nature» stated that diet can adjust insulin levels and improve the anticancer effect of ...

Continue reading

13 Aug
PEG & ADC

Scientists Develop Magical Nanoparticles For Treat The Brain Cancer

  • August 13, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
In recent years, due to the development of medical technology, scientists continue to explore new ways to treat c...

Continue reading

22 Jul
PEG & ADC

How Structure and Ligand-Based Drug Design Shape Modern Drug Discovery

  • October 31, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
In modern drug discovery, two main approaches are widely used: Structure-Based Drug Design (SBDD) and Ligand-Bas...

Continue reading

08 Jul
PEG & ADC

What are the most important things to pay attention to during the preparation of antibody-conjugated drugs?

  • July 8, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody conjugated drugs are formed by linking monoclonal antibodies targeting specific antigens and small molec...

Continue reading

30 Jun
PEG & ADC

New type of cancer immunotherapy: only kills cancer cells, not healthy cells accidentally

  • June 30, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
In 2018, two pioneers in cancer immunotherapy won the Nobel Prize in Physiology or Medicine. This newly pioneered...

Continue reading

26 Jun
PEG & ADC

ADC Linkers And Research Progress In Detail

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
ADC linkers are not only the molecular parts that form covalent connections between antibodies and small molecula...

Continue reading

23 Jun
PEG & ADC

Key Points To Realize The Anti-cancer Potential Of ADC Drugs

  • June 23, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
The past decade has been a decade of accumulation and harvest for ADC. After the second new ADC drug Adcetris (Br...

Continue reading

09 Jun
PEG & ADC

Esophageal cancer activates the ancient virus hidden in the human genome and also provides new targets for cancer treatment

  • October 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
According to the latest global cancer burden data released by the International Agency for Research on Cancer of ...

Continue reading

09 Jun
PEG & ADC

Indian Long Pepper Extract Anti-glioblastoma Drug

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin

Continue reading

09 Jun
PEG & ADC

Acellular Extracellular Matrix Bio-ink Build Tissue And Organ-Specific Microenvironment

  • August 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Tissue engineering is a revolutionary strategy to rebuild new organs or tissues through the use of various biomed...

Continue reading

09 Jun
PEG & ADC

PEG solution therapy in treating acute hepatic encephalopathy

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Scientists from Baylor University Medical Center pointed out, the common drugs used to clean the patient’s intest...

Continue reading

09 Jun
PEG & ADC

ADCs Enfortumab Vedotin Receives Accelerated FDA Approval

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Urothelial cancer accounts for more than 90% of bladder cancer. Patients diagnosed with metastatic disease have a...

Continue reading

09 Jun
PEG & ADC

Dendrimer targeted therapy for cancer

  • July 14, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
In view of the local invasiveness and remote metastasis characteristics of malignant tumors, the treatment effec...

Continue reading

09 Jun
PEG & ADC

Cell therapy of vitamin-lipid nanoparticles to treat sepsis

  • January 12, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
Sepsis is an organ dysfunction caused by the host's abnormal immune response to infection. Sepsis affects millions of people worldwid...

Continue reading

09 Jun
PEG & ADC

New drug for multiple sclerosis! FDA approval of PLEGRIDY (peginterferon beta-1a)

  • August 31, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
Biogen recently announced that the U.S. Food and Drug Administration (FDA) has approved Plegridy (pegylated inte...

Continue reading

09 Jun
PEG & ADC

Folate receptor crystal structure-anti-cancer drug development

  • August 31, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
Folic acid and vitamin B9 is an essential substance for cell growth. Indiana University scientists have revealed...

Continue reading

09 Jun
PEG & ADC

Cleavable & Non- Cleavable Linkers with Antibody-Drug Conjugates

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Antibody-drug conjugates (ADC) have been identified as the main treatment therapy for clinical cancer treatment. The principle of ADC i...

Continue reading

09 Jun
PEG & ADC

The Rise Of 3D Cell Printing Technology

  • August 31, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
What if scientists no longer rely on scarce organ donations, but can build healthy new organs quickly and cheapl...

Continue reading

09 Jun
PEG & ADC

PEG Polypeptides Chemical Modification

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
A polypeptide is a compound formed by multiple amino acids connected by peptide bonds. They are ubiquitous in org...

Continue reading

09 Jun
PEG & ADC

Types of anti-tumor prodrugs that exist

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Prodrugs is a compound through enzyme or nonenzymatic action in the body to release active matter. It has less ac...

Continue reading

09 Jun
PEG & ADC

Have you used these common labeling tools?

  • January 12, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
The antibody or protein labeling refers to covalently linking a target substance (enzyme, fluorescein, biotin) to an antibody or ot...

Continue reading

08 Jun
PEG & ADC

FDA Approves Biogen’s New Alzheimer’s Drug Aducanumab

  • June 8, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
On June 7, the US FDA announced the approval of Biogen/Eisai's Aβ (amyloid β) antibody Aduhelm (aducanumab) for t...

Continue reading

29 May
PEG & ADC

Monoclonal Antibody-drug Stability Optimization

  • October 31, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Monoclonal Antibody-Drug Stability Optimization Monoclonal antibody drugs are essential in biopharmaceuticals, ...

Continue reading

26 May
PEG & ADC

Photoimmune ADC: A New Frontier in Targeted Cancer Therapy

  • November 4, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Photoimmune ADCs represent an innovative type of antibody-drug conjugate (ADC) that combines targeted antibodi...

Continue reading

20 May
PEG & ADC

New Cancer Materials, Nano-Gold Cancer Treatments

  • August 31, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
The history of human struggle with cancer is very long, from surgery, radiotherapy, and chemotherapy, to immunot...

Continue reading

06 May
PEG & ADC

Unlocking the Future: How GPCR-Targeted ADCs Are Changing Cancer Therapy

  • October 31, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
G protein-coupled receptors (GPCRs) are crucial membrane proteins involved in cellular signaling and various dise...

Continue reading

24 Apr
PEG & ADC

Growth factor PEG-fibronectin hydrogel

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Extracellular matrix-derived matrigel contains a variety of growth factors. And it has ECM properties that suppor...

Continue reading

14 Apr
PEG & ADC

Tisotumab vedotin, a new drug for cervical cancer ADC will apply for marketing!

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Cervical cancer originates from the cells of the cervix. The disease is still one of the leading causes of cancer...

Continue reading

06 Apr
PEG & ADC

HER2, the first ADC drug for HER2-positive gastric cancer, approved in Japan

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Abstract Daiichi Sankyo recently announced that Japan’s Ministry of Hea...

Continue reading

29 Mar
PEG & ADC

What is a fluorescent probe?

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Fluorescence is a luminescence phenomenon of photoluminescence. When certain substances are excited by light, ele...

Continue reading

22 Mar
PEG & ADC

Polyethylene Glycol Modification Reagent in Protein Medicine

  • June 9, 2021
  • By axispharm
Facebook Twitter Pinterest linkedin
Modified PEG is also called modified polyethylene glycol, which is a PEG-modified by a chemical modification grou...

Continue reading

16 Mar
PEG & ADC

What is cancer? How should we prevent it?

  • July 4, 2022
  • By axispharm
Facebook Twitter Pinterest linkedin
Cancer refers to malignant tumors originating from epithelial tissues and is the most common type of malignant t...

Continue reading

12 Mar
PEG & ADC

What is ADC(Antibody-drug Conjugates)?

  • May 19, 2024
  • By axispharm
Facebook Twitter Pinterest linkedin
Abstract ADCs combine the high specificity of monoclonal a...

Continue reading

10 Mar
PEG & ADC

What is PEG/PEG-linker?

  • October 7, 2023
  • By axispharm
Facebook Twitter Pinterest linkedin
Polyethylene glycol(PEG) is an ethylene glycol polymer with a relative molecular weight of 200 to 8000 or more t...

Continue reading

axispharm

AxisPharm | ADC technologies & Analytical Services. | High Purity PEG Linkers ADC Linkers Supplier.

5820 Oberlin Drive, Suite 104,San Diego, California 92121, USA

phone:1-858-677-9432
fax: 1-858-228-1081
email: sales@axispharm.com

Services & Pricing
  • Bioanalytical Service
  • Analytical Services
  • Proteomics Services
  • Formulation Services
  • ADC Conjugation Service
  • General Pricing List
  • PK Study Pricing List
  • GCMS GCFID Pricing
  • Proteomics Service Pricing
Products
  • ADC Linkers
  • PEG Linkers
  • Click chemistry tools
  • Acid reactive Linkers
  • Amine reactive Linkers
  • Thiol reactive Linkers
  • Carbonyl reactive Linkers
  • Cleavable Linkers
  • Image Probes
  • Fluorescent Dye
Technical
  • Instrumentation
  • Maldi-TOF Application
  • LCMS
  • GCMS Application
  • Chemistry Services
  • Ion Chromatography – HPIC
  • Titrations
About us
  • About us
  • Contact us
  • Careers
  • FAQ
  • Blog
  • Privacy Policy
  • News
  • Track Order
  • CAS Number
  • SDS

2018-2024 ©Copyright AxisPharm

Facebook Twitter YouTube linkedin
Axispharm payment method
  • Home
  • Services
    • Service Area
      • Bioanalytical Service – PK Studies
      • Analytical Services
      • Proteomics Services
      • Formulation Services
      • Bioconjugation Service
      • Metabolomics Services
      • Oligonucleotides
      • Custom Synthesis Services
      • In Vitro Diagnostic (IVD) Research and Development
    • Test Type
      • Ion Chromatography – HPIC
      • GCMS Analysis
      • LCMS Analysis
      • LCMSMS Analysis Services
      • Maldi-TOF Analysis
      • Q-TOF-LC-MS and TQ-LC-MS analysis of Oligonucleotides
      • Titrations
    • Analyte Type
      • Small Molecules
      • Protein
      • Oligonucleotides
      • Polymers
    • By Industry
      • Consumer
      • Environmental
      • Forensic
      • Pharmaceutical
  • Products
    • PEG Linkers
    • Lipids for Drug Delivery
    • Fluorescent Dye
    • Click Chemistry Linkers
    • Acid reactive Linkers
    • Amine reactive Linkers
    • Carbonyl reactive Linkers
    • Cleavable Linkers
    • DNA
    • Modifier
    • Polymer PEG
    • Probes
    • Thiol reactive Linkers
    • Payloads and Linker modified Payloads
    • synthetic peptides
  • Instrumentation
    • GCMS1
    • ICP-MS
    • Ion Chromatography – HPIC
    • LCMS
    • Maldi-TOF
    • Orbitrap Mass Spectrometer
    • Q-TOF-LC-MS and TQ-LC-MS
    • Titrations
    • TOF and QTOF Mass Spectrometer
  • Quick Links
    • Sample Preparation Guidelines
    • Online Sample Submission
    • Sample Submission Form (PDF)
    • GCMS GCFID Pricing
    • Analytical Pricing
    • PK Study Pricing
    • Proteomics Cost
    • Metabolomics Services Pricing
  • Blog
  • Contact Us
    • About Us
    • Videos
    • News
    • FAQ
    • Product Support
    • Careers
  • Hello, Sign in

Shopping cart

close

Sign in

close


Lost your password?
No account yet? Create an Account
Scroll To Top
Facebook Twitter Pinterest linkedin